Abstract: It has been surprisingly discovered that administration of nitrite to subjects causes a reduction in blood pressure and an increase in blood flow to tissues. The effect is particularly beneficial, for example, to tissues in regions of low oxygen tension. This discovery provides useful treatments to regulate a subject's blood pressure and blood flow, for example, by the administration of nitrite salts. Provided herein are methods of administering a pharmaceutically-acceptable nitrite salt to a subject, for treating, preventing or ameliorating a condition selected from: (a) ischemia-reperfusion injury (e.g., hepatic or cardiac or brain ischemia-reperfusion injury); (b) pulmonary hypertension (e.g., neonatal pulmonary hypertension); or (c) cerebral artery vasospasm.
Type:
Application
Filed:
June 22, 2017
Publication date:
October 5, 2017
Applicants:
The Government of the U.S.A. as represented by the Sec. of the Dept. of Health and Human Services, Loma Linda University, Wake Forest University
Inventors:
Mark T. Gladwin, Alan N. Schechter, Christian J. Hunter, Gordon G. Power, Daniel B. Kim-Shapiro, Richard O. Cannon, III
Abstract: The invention provides compounds that inhibit epoxide hydrolase in therapeutic applications for treating hypertension.
Type:
Application
Filed:
October 27, 2003
Publication date:
May 13, 2004
Applicants:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE GOVERNMENT OF THE U.S., as represented by the Sec. of the Dept. of Health and Human Services
Inventors:
Deanna L. Kroetz, Darryl C. Zeldin, Bruce D. Hammock, Christophe Morisseau